We are focusing on some candidate that could increase the brain activities and improve cognition. BT-11 were developed as a funtional food for cognitive improvement
S100A9 is responsible for the neurodegeneration and cognitive dificits in TG2576 mice. Its knockout is a potential target for the pharmacological therapy of AD.
We have developed some substances and obtained intellectual property rights on many area. For example, DHED were developed as a therapeutic candidate for Alzheimer’s disease.
Establishment of efficacy and safety assessment of human adipose tissue-derived mesenchymal stem cells (hATMSCs) in a nude rat femoralsegmental defect model.